2-(1-Hydroxethyl)-4,8-dihydrobenzo[1,2-b:5,4-b']dithiophene-4,8-dione (BTP-11) enhances the ATRA-induced differentiation in human leukemia HL-60 cells.

[1]  S. Kuo,et al.  Synthesis of 1-substituted 3-pyridinylmethylidenylindolin-2-ones and 1-substituted 3-quinolinylmethylidenylindolin-2-ones as the enhancers of ATRA-induced differentiation in HL-60 cells. , 2008, Bioorganic & medicinal chemistry.

[2]  Jing-Gung Chung,et al.  Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226. , 2008, Biochemical pharmacology.

[3]  Yan Chen,et al.  Catalase potentiates retinoic acid‐induced THP‐1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator‐activated receptor γ , 2007, Journal of leukocyte biology.

[4]  S. Kuo,et al.  Cell differentiation enhancement by hydrophilic derivatives of 4,8-dihydrobenzo[1,2-b:5,4-b']dithiophene-4,8-diones in HL-60 leukemia cells. , 2007, Bioorganic & medicinal chemistry letters.

[5]  Jing-Gung Chung,et al.  1-(3,4-dimethoxyphenyl)-3,5-dodecenedione (I6) induces G1 arrest and apoptosis in human promyelocytic leukemia HL-60 cells. , 2005, Leukemia research.

[6]  Yuan-fang Liu,et al.  All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Tenen,et al.  CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia. , 2003, Blood.

[8]  R. Gallagher.  Retinoic acid resistance in acute promyelocytic leukemia , 2002, Leukemia.

[9]  Ping Zhu,et al.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.

[10]  J. Lekstrom-Himes.  The Role of C/EBPε in the Terminal Stages of Granulocyte Differentiation , 2001 .

[11]  Ø. Bruserud,et al.  New Strategies for the Treatment of Acute Myelogenous Leukemia: Differentiation Induction—Present Use and Future Possibilities , 2000, Stem cells.

[12]  T. Naoe,et al.  Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all‐trans retinoic acid , 2000, British journal of haematology.

[13]  N. Reiner,et al.  1α,25-Dihydroxyvitamin D3–Induced Myeloid Cell Differentiation Is Regulated by a Vitamin D Receptor–Phosphatidylinositol 3-Kinase Signaling Complex , 1999, The Journal of experimental medicine.

[14]  T. Naoe,et al.  Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy , 1999, Leukemia.

[15]  S. Kuo,et al.  Synthesis and cytotoxicity of methyl-4,8-dihydrobenzo[1,2-b:5,4-b']dithiophene-4,8-dione derivatives. , 1999, Bioorganic & medicinal chemistry.

[16]  W. Miller,et al.  CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. , 1999, The Journal of clinical investigation.

[17]  S. Kuo,et al.  Synthesis and cytotoxicity of 2-acetyl-4,8-dihydrobenzodithiophene-4, 8-dione derivatives. , 1998, Journal of medicinal chemistry.

[18]  H. Perlman,et al.  Cell cycle exit upon myogenic differentiation. , 1997, Current opinion in genetics & development.

[19]  F. Lund-Johansen,et al.  Expression of leukocyte differentiation antigens during the differentiation of HL‐60 cells induced by 1,25‐dihydroxyvitamin D3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells , 1995, Journal of leukocyte biology.

[20]  H. Hassan,et al.  New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia , 2004, European Journal of Clinical Pharmacology.

[21]  W. Miller,et al.  Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. , 2001, Blood.

[22]  P. Fenaux,et al.  All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. , 2001, Seminars in hematology.

[23]  F. Appelbaum,et al.  Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. , 2000, Blood.